Xonefit-T 562.5mg Injection
Marketer
Medizia Biotech
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Xonefit-T 562.5mg Injection
Combifit-TX 562.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation and prevents infection spread. Administration must be solely under a physician's direction; adhere strictly to the prescribed schedule. Complete the entire treatment course, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Sufficient rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Xonefit-T 562.5mg Injection
Infections caused by bacteria
Major Benefits of Xonefit-T 562.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xonefit-T 562.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xonefit-T 562.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Xonefit-T 562.5mg Injection works:
The injectable formulation Xonefit-T 562.5mg combines ceftriaxone, a bacterium-fighting antibiotic, with tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, thereby boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xonefit-T 562.5mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xonefit-T 562.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, research involving human subjects is currently insufficient.
Breast feedingCAUTION
Administering Xonefit-T 562.5mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Xonefit-T 562.5mg Injection can potentially reduce vigilance, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xonefit-T 562.5mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering the 562.5mg Xonefit-T Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice before administering. Dosage alteration for Xonefit-T 562.5mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xonefit-T 562.5mg Injection :
Omitting a scheduled dose of Xonefit-T 562.5mg Injection necessitates contacting your physician.
Facts to Know About Xonefit-T 562.5mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently